tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Intellia Therapeutics (NTLA)
NASDAQ:NTLA
US Market
NTLA
Intellia Therapeutics
Overview
Analyst Forecasts
AI Stock Analysis
News & Insights
Financials
Dividends
Technical Analysis
Options
Chart
Earnings
Ownership
Stock Buybacks
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Intellia Therapeutics (NTLA) Stock News & Sentiment

Compare
3,428 Followers
Palantir, Barrick, Intuit, Intellia, Beyond: Trending by Analysts
Premium
Weekend Updates
Palantir, Barrick, Intuit, Intellia, Beyond: Trending by Analysts
18d ago
BYON
GOLD
Intellia Therapeutics: Promising Potential in Biotech with NTLA-2002 Advancements and Strategic Focus
Premium
Ratings
Intellia Therapeutics: Promising Potential in Biotech with NTLA-2002 Advancements and Strategic Focus
23d ago
NTLA
Positive Outlook on Intellia Therapeutics: Buy Rating Supported by Financial Performance and Sector Alignment
Premium
Ratings
Positive Outlook on Intellia Therapeutics: Buy Rating Supported by Financial Performance and Sector Alignment
23d ago
NTLA
Intellia Therapeutics’ Promising Future: Buy Rating Backed by Strong Financials and Program Advancements
Premium
Ratings
Intellia Therapeutics’ Promising Future: Buy Rating Backed by Strong Financials and Program Advancements
25d ago
NTLA
Intellia Therapeutics: Strategic Positioning and Growth Potential Justify Buy Rating
Premium
Ratings
Intellia Therapeutics: Strategic Positioning and Growth Potential Justify Buy Rating
26d ago
NTLA
Intellia Therapeutics: Strong Cash Position and Strategic Cost Reductions Drive Buy Rating and Increased Price Target
Premium
Ratings
Intellia Therapeutics: Strong Cash Position and Strategic Cost Reductions Drive Buy Rating and Increased Price Target
26d ago
NTLA
Intellia Therapeutics: Hold Rating Amid Long-Term Prospects and Strategic Restructuring
Premium
Ratings
Intellia Therapeutics: Hold Rating Amid Long-Term Prospects and Strategic Restructuring
26d ago
NTLA
More NTLA News >

NTLA News on the Web

CRISPR Therapeutics Stock Trades Near 52-Week Low: Time to Buy or Sell?
Zacks
Neutral
Palantir, Barrick, Intuit, Intellia, Beyond: Trending by Analysts
TipRanks News
Neutral
Bank of America Securities Sticks to Their Buy Rating for Intellia Therapeutics (NTLA)
TipRanks News
Neutral
Wall Street's Top 10 Stock Calls This Week - Saturday, March 1
TalkMarkets
Neutral
Intellia Therapeutics, Inc. Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Yahoo Finance
Neutral
William Blair Reaffirms Their Buy Rating on Intellia Therapeutics (NTLA)
TipRanks News
Neutral
Intellia Therapeutics Delivers a Q4 Beat
The Motley Fool
Neutral
Intellia Therapeutics, Inc. Reports Q4 Loss, Tops Revenue Estimates
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
NTLA
Sector Average
Media Buzz
This Week1 articles
Weekly Average0 articles
News Sentiment
This Week50%
Sector Average58%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NTLA’s Media Buzz Sentiment?
Currently, no data Available
What is NTLA’s weekly average amount of articles?
Currently, no data Available
What is NTLA’s News Sentiment?
50% of articles about NTLA were positive this week, compared to its sector average of 58%.
    Healthcare Stocks that are Trending in the News
    PLXProtalix
    DVAXDynavax
    OGNOrganon
    IMVTImmunovant
    RBOTVicarious Surgical
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing